Thyroid nodules and cancers in children

Pediatric Endocrinology Reviews

Volumn 6, Issue 1, 2008, Pages 14-23

  Josefson, Jami ^a   Zimmerman, Donald ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Pediatric thyroid cancer; Pediatric thyroid neoplasms; Pediatric thyroid nodules

Indexed keywords

CALCITONIN; IODINE 123; IODINE 131; PROTEIN P53; PROTEIN RET; PROTEIN TYROSINE KINASE INHIBITOR; RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY; THYROXINE;

ANTIBODY BLOOD LEVEL; ASPIRATION BIOPSY; BLEEDING; BONE MARROW SUPPRESSION; CALCITONIN BLOOD LEVEL; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; CHILD CARE; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL DISORDER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DRUG INDICATION; ECHOGRAPHY; ENVIRONMENTAL FACTOR; EUTHYROIDISM; FACIAL NERVE PARALYSIS; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HORNER SYNDROME; HUMAN; HYPOPARATHYROIDISM; INFERTILITY; LARYNGEAL NERVE; LOBECTOMY; LUNG METASTASIS; LYMPH NODE METASTASIS; NAUSEA; NECK METASTASIS; NERVE INJURY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PUBLIC HEALTH; RADIATION EXPOSURE; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SALIVARY GLAND CANCER; SIALOADENITIS; SMELLING DISORDER; SURVIVAL RATE; SURVIVAL TIME; TASTE DISORDER; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; TREATMENT INDICATION; VOMITING;

CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY, FOLLICULAR; CHILD; DISEASE SUSCEPTIBILITY; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; IODINE RADIOISOTOPES; THYROGLOBULIN; THYROID NEOPLASMS; THYROID NODULE; THYROTROPIN; THYROXINE;

EID: 53849088571     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endoc Relat Cancer 2006;13:427-453
2. Hishinuma A, Fukata S, Kakudo K, Murata Y, Ieiri T. High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid 2005;15:1079-1084
3. Corrias, A, Cassio A, Weber G, Mussa A, Wasniewska M, Rapa A, Gastaldi R, Einaudi S, Baronio F, Vigone MC, Messina MF, Bal M, Bona G, de Sanctis C. Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med 2008;162:526-531
4. Duffy BJ, Fitzgerald PJ. Thyroid cancer in childhood and adolescence: a report on 28 cases. Cancer 1950;3:1018-1032
5. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, Wolden S, Robison L. Abnormalities of the thyroid in survivors of Hodgkins disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85:3227-3232
6. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141:259-277
7. Cohen A, Rovelli A, van Lint MT, Merlo F, Gaiero A, Mulas R, Balduzzi A, Corti P, Uderzo C, Bacigalupo A. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol 2007;25:2449-2454
8. Cohen A, Rovelli A, van Lint MT, Merle F, Gaiero A, Mulas R, Balduzzi A, Corti P, Uderzo C, Bacigalupo A. Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 2001;28:1125-1128
9. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature 1992;359:21
10. Williams ED, Abrosimov A, Bogdanova T, Demidchik EP, Ito M, LiVolsi V, Lushnikov E, Rosai J, Sidorov Y, Tronko MD, Tsyb AF, Vowler SL, Thomas GA. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer 2004;90:2219-2224
11. Pacini F; Vorontsova T, Demidchik EP, Molinaro E, Agate L, Romei C, Shavrova E, Cherstvoy ED, Ivashkevitch Y, Kuchinskaya E, Schlumberger M, Ronga G, Filesi M, Pinchera A. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 1997;82:2219-2224
12. Langsteger W, Koltringer P, Wolf G, Dominik K, Buchinger W, Binter G, Lax S, Eber O. The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer. Eur J Cancer 1993;29:1547-1553
13. Malchoff CD, Malchoff DM. The genetics of hereditary nonmedullary thyroid carcinoma. J Clin Endocrinol Metab 2002;87:2455-2459
14. Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 1997;82:2037-2043
15. Truta B, Allen BA, Conrad PG, Kim YS, Berk T, Gallinger S, Bapat B, Terdiman JP, Sleisenger MH. Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Fam Cancer 2003;2:95-99
16. Eng C: Cowden disease. J Genet Counsel 1997;6:181-192
17. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-5671
18. Halac I, Zimmerman D. Thyroid tumors in children. In: Lifchitz F, ed. Pediatric Endocrinology. New York, NY: Informa 2007;455-473
19. Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, McConahey WM. Papillary thyroid carcinoma in children and adults: long-term follow-up 1039 patients conservatively treated at one institution during three decades. Surgery 1988;104:1157-1166
20. Kushchayeva Y, Duh QY, Kebebew E, D'Avanzo A, Clark OH. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. Am J Surg 2008;195:457-462
21. Rufini V, Salvatori M, Fadda G, Pinnarelli L, Castaldi P, Maussier ML, Galli G. Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer 2007;110:1209-1217
22. Bounacer A, Wicker R, Caillou B, Cailleux AF; Sarasin A, Schlumberger M, Suárez HG. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 1997;15:1263-1273
23. Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, Sherman Al, Lee JE, Evans DB. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 2005;15:531-544
24. Learoyd DL, Messina M, Zedenius J, Robinson BG. Molecular genetics of thyroid tumors and surgical decision-making. World J Surg 2000;24:923-933
25. Grigsby PW, Gal-Or A, Michalski JM, Doherty GM. Childhood and adolescent thyroid carcinoma. Cancer 2002;95:724-729
26. Pacini F, Mariotti S, Formica N, Elisei R, Anelli S, Capotorti E, Pinchera A. Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome. Acta Endocrinol (Copenh) 1988;119:373-380
27. Hung W. Solitary thyroid nodules in 93 children and adolescents, a 35-years experience. Horm Res 1999;52:15-18
28. Lafferty AR, Batch JA. Thyroid nodules in childhood and adolescence-thirty years of experience. J Pediatr Endocrinol Metab 1997;10:479-486
29. Khurana KK, Labrador E, Izquierdo R, Mesonero CE, Pisharodi LR. The role of fine-needle aspiration biopsy in the management of thyroid nodules in children, adolescents, and young adults: a multi-institutional study. Thyroid 1999;9:383-386
30. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 2007;36:707-735
31. Stevens C, Al-Mahmeed H, Blair G, Prasil P, Haider F, Sweeney B, Cowan K, Butter A, Roessingh AD, Bouchard S, Weinsheimer R, Yanchar N, Alfadhli W, Fitzgerald P, Ryckman J, Puligandla P. The Canadian Pediatric Thyroid Nodule Study: an evaluation of current management practices. J Ped Surg 2008;43:826-830
32. Reiners C. The diagnosis of thyroid cancer. In Biersack HJ, Grunwald F, ed. Thyroid Cancer. Berlin, Germany: Springer 2005;71-81
33. Corrias A, Einaudi S, Chiorboli E, Weber G, Crinò A, Andreo M, Cesaretti G, de Sanctis L, Messina MF, Segni M, Cicchetti M, Vigone M, Pasquino AM, Spera S, de Luca F, Mussa GC, Bona G. Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches. J Clin Endocrinol Metab 2001;86:4644-4648
34. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM: Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-142
35. Gharib H, Zimmerman D, Goellner JR, Bridley SM, LeBlanc SM. Fine needle aspiration biopsy: use in diagnosis and management of pediatric thyroid diseases. Endocr Pract 1995;1:9-13
36. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998;124:958-964
37. Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Francis GL. Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma. J Pediatr Surg 1999;34:1799-1804
38. Taylor T, Specker B, Robbins J, Sperling M, Ho M, Ain K, Bigos ST, Brierley J, Cooper D, Haugen B, Hay I, Hertzberg V, Klein I, Klein H, Ladenson P, Nishiyama R, Ross D, Sherman S, Maxon HR. Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 1998;129:622-627
39. Kloos RT. Papillary thyroid cancer: medical management and follow-up. Curr Treat Options Oncol 2005;6:323-338
40. Pelizzo MR, Boschin IM, Toniato A, Piotto A, Bernante P, Pagetta C, Rampin L, Rubello D. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol. 2006;32:1144-1148
41. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, Ain KB, Bigos ST, Brierley JD, Haugen BR, Klein I, Robbins J, Sherman SI, Taylor T, Maxon HR 3rd. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 1998;8:737-744
42. Urhan M, Dadparvar S, Mavi A, Houseni M, Chamroonrat W, Alavi A, Mandel SJ. Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement. Eur J Nucl Med Mol Imaging 2007;34:112-117
43. Park HM. Stunned thyroid after high-dose I-131 imaging. Clin Nucl Med 1992;17:501-502
44. Mandel SJ, Shankar LK, Yamamoto BF, Alavi A. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid carcinoma. Clin Nucl Med 2001;26:6-9
45. 131I-scanning: avoidance of negative therapeutic uptake due to stunning. Clin Endocrinol 2001;55:515-521
46. 123I [abstract]. In: Program and Abstracts: The Endocrine Society's 89th Annual Meeting, 2007 June 2-5; Toronto, Canada, P3-610
47. Morris LF, Waxman AD, Braunstein GD. Thyroid stunning. Thyroid 2003;13:333-340
48. 131I doses in children. In: Robbins J, ed. Treatment of Thyroid Cancer in Children, US Department of Energy. Publication No: EOH-0406 1993;127-135
49. Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID. The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998;83:4195-4203
50. Rosário PW, Borges MA, Valadão MM, Vasconcelos FP, Rezende LL, Padrão EL, Barroso AL, Purisch S. Is adjuvant therapy useful in patients with papillary carcinoma smaller than 2 cm? Thyroid 2007;17:1225-1228
51. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002;26:879-875
52. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid 2002;12:683-702
53. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Mang O, Lau WH. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Pediatr Blood Cancer 2004;42:176-183
54. Zimmerman D, Hay I, Bergstralh E. Papillary Thyroid Carcinoma in Children. In: Robbins J, ed. Treatment of Thyroid Cancer in Children, US Department of Energy. Publication No: EOH-0406 1993;3-10
55. Hay I, Thompson G, Reinalda M, Grant C, Lteif A, McIver B, Schwenk W, Goellner J. Impact of initial therapy on long-term outcome in papillary thyroid carcinoma (PTC) managed during childhood and adolescence: a battle won or a war lost? Thyroid 2004;14:684
56. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003;89:1638-1644
57. Dinauer C, Francis GL. Thyroid cancer in children. Endocrinol Metab Clin North Am 2007;36:779-806
58. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005;90:5566-5575
59. Pacini F, Mariotti S, Formica N, Elisei R. Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumor outcome. Acta Endocrinol 1988;119:373-380
60. Habra MA, Vassilopoulou-Sellin R Contribution of routine chest x-ray in the long-term follow-up of patients with differentiated thyroid carcinoma. Thyroid 2006;16(3):303-306
61. Kuijt WJ, Huang SA. Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal. J Clin Endocrinol Metab 2005;90(11)6123-6125
62. Iorcansky S, Herzovich V, Qualey RR, Tuttle RM. Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer. J Clin Endocrinol Metab 2005;90:6553-6555
63. Baskin HJ. Dectection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes. Thyroid 2004;14:959-963
64. Leboulleux S, Schroeder PR, Schlumberger M, Ladenson PW. The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers. Nat Clin Pract Endocrinol Metab 2007;2:112-121
65. Gill JR, Reyes-Múgica M, Iyengar S, Kidd KK, Touloukian RJ, Smith C, Keller MS, Genel M. Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy. J Pediatr 1996;129:459-464
66. Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells, Jr SA. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J Ped Surg 1996;31:177-182
67. Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB. Multiple endocrine neoplasia type 2 evaluation of genotype-phenotype relationship. Arch Surg 2003;138:409-416
68. Jimenez C, Hu MI, Gagel R. Management of Medullary Thyroid Carcinoma. Endocrinol Metab Clin N Am 2008;37:481-496
69. Vassilopoulou-Sellin R, Goepfert H, Raney B, Schultz PN. Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up. Head Neck. 1998;20:549-555
70. Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill CS Jr, Hickey RC, Samaan NA. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine 1984;63:319-342
71. Leboulleux S, Travagli JP, Caillou B, Laplanche A, Bidart JM, Schlumberger M, Baudin E. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course. Cancer 2002;94:44-50